During the COVID-19 outbreak, CSL is here for our patients and our larger world community.
CSL condemns the invasion of Ukraine and we are supporting multiple humanitarian relief efforts to help those impacted by this unjust act.
Latest CSL News
CSL RAI Awardees Announced
CSL Extends Reach of Global Research Acceleration Initiative with Freshly Inked Partnerships to Fast-Track Research Programs
Bernadette Murdoch to lead CSL's Reputation CoE
Bernadette Murdoch, an experienced Australian and global corporate affairs and communications leader across multiple industri…
CSL presents new research and development center in Marburg, Germany
MARBURG, GERMANY The new facility, once fully open later this calendar year, will be CSL’s largest R&D site under one roof, …
CSL Announces Positive Results for Garadacimab
CSL is on track to file for regulatory approvals at end of current fiscal year and will present full data set at an upcoming …
CSL Announces Carbon Targets
CSL advances its vision for a more sustainable future by setting new, tangible targets for carbon emissions reductions
CSL launches new brand identity
Global biotech leader CSL today announced that all business units will be united as one family under the CSL global brand.
CSL Welcomes US Court Ruling
Statement attributable to Greg Boss, Executive Vice President - Legal, and CSL Limited Group General Counsel.